EnWave Corporation

EnWave Corporation

December 06, 2007 08:30 ET

EnWave Sells nutraREV Batch Unit; Delivers Continuous Technology to Commercial Testing Partner

VANCOUVER, BRITISH COLUMBIA--(Marketwire - Dec. 6, 2007) - EnWave Corporation (TSX VENTURE:ENW)(FRANKFURT:E4U) ("EnWave" or "the Company") is pleased to announce that, after a successful test period, the Company has now sold an 8 kW batch nutraREV food dehydration unit to the Haida Gwaii Community Future Co-Operative on the Queen Charlotte Islands.

The Co-op, a group of local businesses and members of the general public, are planning to use the nutraREV dehydration technology to process local Queen Charlotte Island products to help build a community-based business that will stimulate local employment. The Co-op is currently using nutraREV to produce dried wild chanterelle mushrooms.

This marks the fifth batch nutraREV machine that EnWave has sold for testing or batch dehydration of fruits and vegetables.

nutraREV uses proprietary Radiant Energy Vacuum (REV) technology developed at the University of British Columbia to dehydrate fruits and vegetables. The technology offers significant potential commercial benefits including more efficient processing, better quality food and higher nutritional content than current processing techniques such as freeze-drying and air-drying.

EnWave has also delivered its new continuous nutraREV food dehydration technology capable of large-scale production to a commercial partner in the food processing industry in Richmond, B.C. The Company will begin a testing program to determine the commercial viability of this technology with a target production rate of 100 kilograms of dried berries per hour. EnWave hopes to receive the results from this testing program by Q2, 2008. If the testing is successful, EnWave will start approaching potential strategic partners to assist with the commercialization and marketing of this equipment in the global food processing industry.

"We believe that 2008 will be a pivotal year for EnWave enabling the Company to validate the commercial potential of its radiant energy vacuum technology," said Dr. Tim Durance, Chairman and Co-CEO of EnWave. "The incorporation of continuous nutraREV technology into a commercial-scale production line marks a major milestone for EnWave which will provide us with crucial information needed to market this technology in the food industry."

About EnWave

Using proprietary technologies developed in conjunction with the University of British Columbia, EnWave is focused on the development of new methods of dehydrating biological materials using Radiant Energy Vacuum technology under its bioREV and nutraREV brands. REV technology combines microwave energy transfer with pressure control to dehydrate and alter structures and drive chemical reactions, thereby creating unique product characteristics for both food products and medical applications that include dry vaccines. More information about EnWave is available at www.enwave.net.

EnWave Corporation

Dr. Tim Durance, Chairman & CO-CEO

Safe Harbour for Forward-Looking Information Statements: This release may contain forward-looking information based on management's expectations, estimates and projections. All statements that address expectations or projections about the future, including statements about the Company's strategy for growth, product development, market position, expected expenditures and financial results are forward-looking statements. Forward looking statements in this press release include: "hopes to receive", "plans to", and "should be delivered". These statements are not guarantees of future performance and involve a number of risks, uncertainties and assumptions: there is no guarantee that the Company's bioREV and nutraREV technology can or will be used to dehydrate vaccines, antibodies or other biological materials on a commercial scale or improve processes in the food industry; even if the Company's bioREV and nutraREV technology can be used as described in this news release, there is no guarantee that such use will result in orders for the Company's bioREV and nutraREV technology.

The TSX Venture Exchange has neither approved nor disapproved the information contained herein.

Contact Information

  • EnWave Corporation
    Dr. Tim Durance
    Chairman and Co-CEO
    (604) 806-6110
    EnWave Corporation
    Mr. John McNicol
    President and Co-CEO
    (604) 806-6110
    (604) 806-6112 (FAX)
    Website: www.enwave.net